Gail Boudreaux, President and CEO at Elevance Health, Inc. (ELV), sold 65,900 shares at $503.67 ($33.0M) on 2024-07-22, disclosed to the SEC on 2024-07-23.
Scheduled sale ($33.0M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $498.50 | 1,100 | $548K | 1.7% |
| 2 | $500.36 | 20,779 | $10.4M | 31.5% |
| 3 | $500.36 | 20,779 | $10.4M | 31.5% |
| 4 | $501.40 | 6,621 | $3.3M | 10.1% |
| 5 | $501.40 | 6,621 | $3.3M | 10.1% |
| 6 | $502.23 | 2,250 |
| $1.1M |
| 3.4% |
| 7 | $502.23 | 2,250 | $1.1M | 3.4% |
| 8 | $503.67 | 1,000 | $504K | 1.5% |
| 9 | $504.27 | 2,250 | $1.1M | 3.4% |
| 10 | $504.27 | 2,250 | $1.1M | 3.4% |
| Total | $500.98 avg | 65,900 | $33.0M | 100% |
| Filing → |
| ANTM | BUY | 2020-01-31 | $2.0M | — | Filing → |
| ZBH | BUY | 2019-02-06 | $500K | — | Filing → |
| NVAX | BUY | 2016-09-21 | $145K | — | Filing → |